Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.
about
Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleasesRapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphologyA Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in MicImmunizing adult female mice with a TcpA-A2-CTB chimera provides a high level of protection for their pups in the infant mouse model of cholera.Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coliBottom-up and top-down solid-state NMR approaches for bacterial biofilm matrix composition.Characterization of the Vibrio cholerae extracellular matrix: a top-down solid-state NMR approach.Host-like carbohydrates promote bloodstream survival of Vibrio vulnificus in vivo.A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles.O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in BangladeshImmunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles.Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response.Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.Proteomic analysis of Vibrio cholerae outer membrane vesicles.Biosynthetically engineered lipopolysaccharide as vaccine adjuvant.A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination.
P2860
Q27333153-084BB568-AABF-4365-96E0-BA66BC5C0C18Q30628895-BBD56469-EC15-4603-830C-E4C651F765F5Q34484003-8C09147A-8D0C-44A3-9883-07BC6AC79EFEQ34633942-46232DBA-995F-473E-A412-84265CCC7525Q34990310-31F69C5F-DE3A-4F32-98B4-748DC712520AQ35247793-D08223C9-1BE8-49D1-AD78-965D5B2156E7Q35523883-A21CA1E1-CB09-495E-A297-720694E20107Q35833811-B72FF42E-9F6C-4386-8B58-A8AFDEF8F6ACQ35935738-724834FE-ABB0-4360-8BF8-71D4509C52D9Q36881533-5ED39A7D-95D0-4A7F-A994-69959E0100FBQ37029159-18359940-2B18-43DC-92A0-234496448B36Q37287207-BF77141D-6AD5-4118-9F7F-203796AD020DQ37547002-75C17007-C401-446E-9788-FC7364610401Q37711925-CA7ABA3A-4F09-429D-9CBB-FD78771B767CQ38386726-C4F69629-B17D-42EE-B5BF-FBA52D755F5AQ40489920-8C842BF3-A01C-4B81-BC2D-0B750AA6163FQ47105309-05D92AB7-3887-421A-9931-BD414073CBD3Q48321872-725CEB79-DDCA-41FF-AD95-08722142BF04
P2860
Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lipopolysaccharide modificatio ...... the major protective antigen.
@en
type
label
Lipopolysaccharide modificatio ...... the major protective antigen.
@en
prefLabel
Lipopolysaccharide modificatio ...... the major protective antigen.
@en
P2093
P2860
P50
P356
P1476
Lipopolysaccharide modificatio ...... l the major protective antigen
@en
P2093
Deborah R Leitner
Kristina Schild-Prüfert
Sandra Feichter
P2860
P304
P356
10.1128/IAI.01382-12
P407
P577
2013-04-29T00:00:00Z